D49- neoplasms
Dexamethasone-free anti-emetic regimen in multi-day chemotherapy
Who can joinAdults
Age18–70 years
Kind of studyPhase 3: compared with usual treatment
What it testsA medicine
The full list of who can and cannot join is on the registry. Ask the trial team, or write to us and we will explain it in simple words.
Contact hospital
The registry names this hospital as the trial's main contact. Ask them which hospitals are taking patients.
ACTREC,TMCNavi MumbaiDirections ↗
Registry summary (technical)
A randomized, open-label, phase III trial evaluating dexamethasone-free anti-emetic regimen versus standard dexamethasone-containing regimen in patients receiving multi-day highly emetogenic chemotherapy (DEXA-FREE). - Anti Emetic regimen , multi day ,chemo
Sponsor: ACTREC, TMC
CTRI/2025/10/096235 on CTRI, India's trial registry
Source: Clinical Trials Registry – India (CTRI), via WHO ICTRP, data of 12 Oct 2026
Last updated on the registry 27 Apr 2026 · read by us 5 Nov 2026